Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPsDARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs
VS
Johnson & Johnson Innovative MedicineJohnson & Johnson Innovative Medicine
DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs

DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs

N/A

Last Update: 22/04/2026

View Profile
Between 750 and 799
https://www.darzalexhcp.com/
753/1000Fair

Please see Important Safety Information below in the pinned post and at https://www.darzalexhcp.com/ISI.   This product information is intended for US Healthcare Professionals only.   DARZALEX® and DARZALEX FASPRO® are products of Janssen Biotech, Inc., and are not asso...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:0
Subsidiaries:16
12-month incidents
0
Known data breaches
0
Attack type number
0
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

N/A

Last Update: 31/03/2026

View Profile
807/1000Good

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with co...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:37,729
Subsidiaries:10
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs

DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Johnson & Johnson Innovative Medicine in 2026.

Incidents

Incident History - DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs (X = Date, Y = Severity)

DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Johnson & Johnson Innovative Medicine (X = Date, Y = Severity)

Johnson & Johnson Innovative Medicine cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs

DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs

Incidents
No explicit notable incidents reported.
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

Incidents
No explicit notable incidents reported.

FAQ

Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one has the best AI Cybersecurity Score ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one has experienced more cyber incidents in the past ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one has experienced more cyber incidents this year ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one ransomware attack ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one data breach ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one targeted cyberattack ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one vulnerability ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one holds the most compliance certifications ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one holds the fewest compliance certifications ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one has the most subsidiaries ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs company and Johnson & Johnson Innovative Medicine company, which one has the largest number of employees ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs and Johnson & Johnson Innovative Medicine, which company holds both SOC 2 Type 1 certifications ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs and Johnson & Johnson Innovative Medicine, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs or Johnson & Johnson Innovative Medicine ?
Which company is PCI DSS compliant - DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs or Johnson & Johnson Innovative Medicine ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs and Johnson & Johnson Innovative Medicine, which company complies with HIPAA regulations for healthcare data ?
Between DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for HCPs and Johnson & Johnson Innovative Medicine, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-57980
SUMMARY

Authentication bypass using an alternate path or channel in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform tampering over a network.

PUBLISHED
Date2026-07-17
UPDATED
Date2026-07-17
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-56741
SUMMARY

JLine is a Java library for handling console input. Prior to 3.30.14, 4.0.16, and 4.2.1, the JLine3 Telnet server remote-telnet module does not apply an upper bound to terminal dimensions received via the Telnet NAWS option, and TelnetIO.handleNAWS() in TelnetIO.java:856-879 reads client-supplied width and height as 16-bit unsigned integers and passes values such as 65535x65535 to setTerminalGeometry(), allowing an unauthenticated remote attacker to repeatedly alternate values and trigger continuous expensive rendering work that causes CPU exhaustion and denial of service. This issue is fixed in versions 3.30.14, 4.0.16, and 4.2.1.

PUBLISHED
Date2026-07-17
UPDATED
Date2026-07-17
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-56740
SUMMARY

JLine is a Java library for handling console input. Prior to 3.30.14, 4.0.16, and 4.2.1, the JLine3 Telnet server remote-telnet module does not limit the number of environment variables a client may inject via the Telnet NEW-ENVIRON option, and TelnetIO.readNEVariables() in TelnetIO.java:1127-1180 stores each variable pair in a HashMap held by ConnectionData, allowing an unauthenticated attacker to flood unique variable pairs before the terminating IAC SE byte and exhaust JVM heap memory with an OutOfMemoryError. This issue is fixed in versions 3.30.14, 4.0.16, and 4.2.1.

PUBLISHED
Date2026-07-17
UPDATED
Date2026-07-17
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-56171
SUMMARY

Exposure of private personal information to an unauthorized actor in Windows RDP allows an unauthorized attacker to disclose information over a network.

PUBLISHED
Date2026-07-17
UPDATED
Date2026-07-17
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:N
IMPACT SCORE
4.2
EXPLOITABILITY
2.8
CVE-2026-54335
SUMMARY

Feathersjs is a framework for creating web APIs and real-time applications with TypeScript or JavaScript. In 5.0.44 and earlier, the _.merge(target, source) utility exported by @feathersjs/commons recursively merges source into target by iterating Object.keys(source). When source was produced by JSON.parse and contains a __proto__, constructor, or prototype key, that key is returned as an own-enumerable property; the recursive merge then resolves target['__proto__'] to Object.prototype and writes attacker-supplied properties onto it, polluting the prototype for all plain objects in the process for the lifetime of the Node process. This issue is fixed in version 5.0.45.

PUBLISHED
Date2026-07-17
UPDATED
Date2026-07-17
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.2